Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Melnick

Showing results (231-240 of 322) with videos related to

Pageof 33
Sort By:
Blood|August 8, 2018
PRMT5 interacts with the BCL6 oncoprotein and is required for germinal center formation and lymphoma cell survivalXiaoqing Lu, Tharu M Fernando, Chen Lossos, et al.
Cancer Discovery|February 20, 2019
BCL6 Evolved to Enable Stress Tolerance in Vertebrates and Is Broadly Required by Cancer Cells to Adapt to StressTharu M Fernando, Rossella Marullo, Benet Pera Gresely, et al.
Blood|March 28, 2015
A roadmap for discovery and translation in lymphomaDavid M Weinstock, Riccardo Dalla-Favera, Randy D Gascoyne, et al.
Hemasphere|January 15, 2026
<i>Tet2</i> deficiency promotes IgG1+ B-cell expansion and differentiation blockade through deregulation of the <i>Nfkbia</i>-c-Rel axisHussein Ghamlouch, Michaël Degaud, Veronique Della-Valle, et al.
Nature Communications|June 11, 2024
Direct RNA sequencing of astronaut blood reveals spaceflight-associated m6A increases and hematopoietic transcriptional responsesKirill Grigorev, Theodore M Nelson, Eliah G Overbey, et al.
Plos One|April 23, 2020
The oncogene BCL6 is up-regulated in glioblastoma in response to DNA damage, and drives survival after therapyMarie-Sophie Fabre, Nicole M Stanton, Tania L Slatter, et al.
The Journal of Experimental Medicine|January 30, 2013
Notch activation inhibits AML growth and survival: a potential therapeutic approachSankaranarayanan Kannan, Robert M Sutphin, Mandy G Hall, et al.
Journal of Medicinal Chemistry|July 5, 1996
Bis tertiary amide inhibitors of the HIV-1 protease generated via protein structure-based iterative designM Melnick, S H Reich, K K Lewis, et al.
Haematologica|September 11, 2025
Wild-type p53 overexpression in <i>NPM1</i>-mutated acute myeloid leukemia: potential implications for disease biology and therapy responsePaul D Barone, Siarhei Dzedzik, Ashley S Kleinman, et al.
Cancer Research|October 16, 2012
Methylome profiling reveals distinct alterations in phenotypic and mutational subgroups of myeloproliferative neoplasmsSangeeta Nischal, Sanchari Bhattacharyya, Maximilian Christopeit, et al.
Pageof 33

Showing results (231-240 of 322) with videos related to

Sort By:
Pageof 33
Blood|August 8, 2018
PRMT5 interacts with the BCL6 oncoprotein and is required for germinal center formation and lymphoma cell survivalXiaoqing Lu, Tharu M Fernando, Chen Lossos, et al.
Cancer Discovery|February 20, 2019
BCL6 Evolved to Enable Stress Tolerance in Vertebrates and Is Broadly Required by Cancer Cells to Adapt to StressTharu M Fernando, Rossella Marullo, Benet Pera Gresely, et al.
Blood|March 28, 2015
A roadmap for discovery and translation in lymphomaDavid M Weinstock, Riccardo Dalla-Favera, Randy D Gascoyne, et al.
Hemasphere|January 15, 2026
<i>Tet2</i> deficiency promotes IgG1+ B-cell expansion and differentiation blockade through deregulation of the <i>Nfkbia</i>-c-Rel axisHussein Ghamlouch, Michaël Degaud, Veronique Della-Valle, et al.
Nature Communications|June 11, 2024
Direct RNA sequencing of astronaut blood reveals spaceflight-associated m6A increases and hematopoietic transcriptional responsesKirill Grigorev, Theodore M Nelson, Eliah G Overbey, et al.
Plos One|April 23, 2020
The oncogene BCL6 is up-regulated in glioblastoma in response to DNA damage, and drives survival after therapyMarie-Sophie Fabre, Nicole M Stanton, Tania L Slatter, et al.
The Journal of Experimental Medicine|January 30, 2013
Notch activation inhibits AML growth and survival: a potential therapeutic approachSankaranarayanan Kannan, Robert M Sutphin, Mandy G Hall, et al.
Journal of Medicinal Chemistry|July 5, 1996
Bis tertiary amide inhibitors of the HIV-1 protease generated via protein structure-based iterative designM Melnick, S H Reich, K K Lewis, et al.
Haematologica|September 11, 2025
Wild-type p53 overexpression in <i>NPM1</i>-mutated acute myeloid leukemia: potential implications for disease biology and therapy responsePaul D Barone, Siarhei Dzedzik, Ashley S Kleinman, et al.
Cancer Research|October 16, 2012
Methylome profiling reveals distinct alterations in phenotypic and mutational subgroups of myeloproliferative neoplasmsSangeeta Nischal, Sanchari Bhattacharyya, Maximilian Christopeit, et al.
Pageof 33